Manipal Health Enterprises has announced the price band for its highly anticipated ₹9,275 crore initial public offering (IPO) at ₹560-590 per share. The public issue will open for subscription on July 29 and close on July 31, making it one of the largest IPOs by an Indian healthcare company.
The Bengaluru-based hospital chain, which operates the Manipal Hospitals network, is looking to raise funds to strengthen its financial position and support future expansion. The IPO consists of a fresh issue of shares worth ₹8,000 crore, while the remaining amount will come through an offer for sale (OFS) by existing shareholders.
The bidding process for anchor investors is scheduled for July 28, a day ahead of the public issue. Following the subscription period and allotment process, the company’s shares are expected to be listed on both the BSE and NSE.
The fresh capital raised through the IPO will largely be used to repay debt, helping the company improve its balance sheet. Manipal Health has said reducing borrowings remains a key priority, and the fundraising is expected to significantly lower its debt levels after listing.
Apart from debt repayment, the hospital operator plans to accelerate its expansion plans. The company intends to invest nearly ₹4,000 crore over the next three to four years to add around 2,400 hospital beds across its network. At present, Manipal Health operates 49 hospitals with a combined capacity of more than 13,000 beds, making it one of India’s largest healthcare providers.
The IPO also offers an exit opportunity for some existing investors. Global investment firms Temasek and TPG-backed entities are among the shareholders that will partially dilute their stakes through the offer for sale.
Market participants are closely tracking the issue, with the IPO drawing attention even before subscriptions begin. Grey market trends currently suggest a positive listing premium, although analysts caution that such unofficial indicators should not be viewed as a guarantee of listing-day performance.
India’s healthcare sector has witnessed strong momentum in recent years, driven by increasing demand for quality medical services, rising health insurance coverage, higher healthcare spending and greater awareness among patients. Large hospital chains have also continued expanding into new cities to meet growing demand for advanced medical care.
Manipal Health has strengthened its position through both organic growth and strategic acquisitions over the years. The company now competes with major listed hospital operators such as Apollo Hospitals, Max Healthcare and Fortis Healthcare, making it one of the country’s leading integrated healthcare networks.
The IPO comes at a time when India’s primary market continues to witness healthy investor participation despite global economic uncertainties. Strong demand for recent public issues has encouraged several companies across sectors to tap the capital markets.
For investors, Manipal Health’s public issue represents an opportunity to participate in India’s expanding healthcare industry. However, experts recommend evaluating the company’s financial performance, future growth strategy, valuation and associated risks before investing, instead of relying only on grey market sentiment.
With an extensive hospital network, ambitious expansion plans and a clear focus on improving its financial strength, Manipal Health’s ₹9,275 crore IPO is expected to be one of the most closely watched public offerings in the Indian stock market this year.
Also Read: Fintechs oppose NPCI’s default UPI plan
